FDA Accepts Integral Molecular's Membrane Proteome Array™ Qualification Plan, Advancing the Platform for Approval as a Drug Development Tool
Integral Molecular, a leader in antibody discovery technologies, is proud to announce that the FDA has accepted their ...
RedHill Biopharma Ltd.: RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer
The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...
Donald Trump and Elon Musk want to dismantle USAID. Which countries will be hit hardest?
Since taking office on January 20, US President Donald Trump has temporarily frozen all foreign assistance and fired hundreds ...